Clinical trial
Managed Ventricular Pacing ("MVP") Trial
NCT00281099 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Terminated
Key facts
| NCT number | NCT00281099 |
|---|---|
| Title | Managed Ventricular Pacing ("MVP") Trial |
| Official title | MVP Trial (Managed Ventricular Pacing ("MVP") Versus Backup Ventricular Pacing at a Rate of 40 Beats Per Minute ("VVI 40") Pacing Trial) |
| Acronym | MVP |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Collaborators | Medtronic Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Heart Disease |
| Intervention type | Device |
| Interventions | ICD (Implantable Cardioverter Defibrillator) |
| Enrollment | 1,031 |
| Start date | Oct 1, 2004 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jan 24, 2006 |
| Last update posted | Aug 3, 2010 |
| Countries | Austria, Canada, Denmark, France, Germany, Israel, Italy, Norway, Spain, Switzerland, United Kingdom, United States |
At a glance
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: